Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)
Others
Ratios

BioNexus Gene Lab (BGLC) Interest Expenses (2021 - 2025)

Historic Interest Expenses for BioNexus Gene Lab (BGLC) over the last 5 years, with Q3 2025 value amounting to $6482.0.

  • BioNexus Gene Lab's Interest Expenses rose 466.66% to $6482.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $22082.0, marking a year-over-year increase of 1314.24%. This contributed to the annual value of $21146.0 for FY2024, which is 5181.28% up from last year.
  • Per BioNexus Gene Lab's latest filing, its Interest Expenses stood at $6482.0 for Q3 2025, which was up 466.66% from $4879.0 recorded in Q2 2025.
  • BioNexus Gene Lab's 5-year Interest Expenses high stood at $6482.0 for Q3 2025, and its period low was -$4762.0 during Q4 2022.
  • Moreover, its 5-year median value for Interest Expenses was $3815.5 (2021), whereas its average is $2027.4.
  • Data for BioNexus Gene Lab's Interest Expenses shows a peak YoY increase of 30555.02% (in 2023) and a maximum YoY decrease of 23117.72% (in 2023) over the last 5 years.
  • Quarter analysis of 5 years shows BioNexus Gene Lab's Interest Expenses stood at -$3986.0 in 2021, then dropped by 19.47% to -$4762.0 in 2022, then skyrocketed by 187.84% to $4183.0 in 2023, then skyrocketed by 38.94% to $5812.0 in 2024, then increased by 11.53% to $6482.0 in 2025.
  • Its Interest Expenses stands at $6482.0 for Q3 2025, versus $4879.0 for Q2 2025 and $4909.0 for Q1 2025.